Syndax Pharmaceuticals, Inc. (SNDX) Net income 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$285.4MFY2025 · since FY2016: -$44.5M → -$285.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$285.4M | +10.5% |
| FY2024 | -$318.8M | -52.2% |
| FY2023 | -$209.4M | -40.3% |
| FY2022 | -$149.3M | -699.6% |
| FY2021 | $24.9M | +134.0% |
| FY2020 | -$73.2M | -30.5% |
| FY2019 | -$56.0M | +24.2% |
| FY2018 | -$74.0M | -21.6% |
| FY2017 | -$60.8M | -36.7% |
| FY2016 | -$44.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice